SILO has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
SILO has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
As of today (2024-06-08), SILO Pharma's current share price is $1.16. SILO Pharma's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was $2.19. SILO Pharma's Cyclically Adjusted PB Ratio for today is 0.53.
The historical rank and industry rank for SILO Pharma's Cyclically Adjusted PB Ratio or its related term are showing as below:
During the past years, SILO Pharma's highest Cyclically Adjusted PB Ratio was 19.47. The lowest was 0.54. And the median was 3.06.
SILO's Cyclically Adjusted PB Ratio is ranked better thanThe Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.
SILO Pharma's adjusted book value per share data for the three months ended in Mar. 2024 was $1.868. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $2.19 for the trailing ten years ended in Mar. 2024.
The historical data trend for SILO Pharma's Cyclically Adjusted PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SILO Pharma Quarterly Data | ||||||||||||||||||||
Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | |
Cyclically Adjusted PB Ratio | Get a 7-Day Free Trial | 1.00 | 0.95 | 0.75 | 0.66 | 0.89 |
For the Biotechnology subindustry, SILO Pharma's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Biotechnology industry and Healthcare sector, SILO Pharma's Cyclically Adjusted PB Ratio distribution charts can be found below:
* The bar in red indicates where SILO Pharma's Cyclically Adjusted PB Ratio falls into.
Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.
The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.
SILO Pharma's Cyclically Adjusted PB Ratio for today is calculated as
Cyclically Adjusted PB Ratio | = | Share Price | / | Cyclically Adjusted Book per Share |
= | 1.16 | / | 2.19 | |
= | 0.53 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SILO Pharma's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:
For example, SILO Pharma's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:
Adj_Book | = | Book Value per Share | / | CPI of Mar. 2024 (Change) | * | Current CPI (Mar. 2024) |
= | 1.868 | / | 131.7762 | * | 131.7762 | |
= | 1.868 |
Current CPI (Mar. 2024) = 131.7762.
SILO Pharma Quarterly Data
Book Value per Share | CPI | Adj_Book | |
201406 | 2.161 | 100.560 | 2.832 |
201409 | 2.388 | 100.428 | 3.133 |
201412 | 2.342 | 99.070 | 3.115 |
201503 | 2.407 | 99.621 | 3.184 |
201506 | 2.436 | 100.684 | 3.188 |
201509 | 1.992 | 100.392 | 2.615 |
201512 | 1.936 | 99.792 | 2.556 |
201603 | 1.852 | 100.470 | 2.429 |
201606 | 1.419 | 101.688 | 1.839 |
201609 | 0.988 | 101.861 | 1.278 |
201612 | 0.846 | 101.863 | 1.094 |
201703 | 1.588 | 102.862 | 2.034 |
201706 | 1.513 | 103.349 | 1.929 |
201709 | 0.994 | 104.136 | 1.258 |
201712 | 1.201 | 104.011 | 1.522 |
201803 | 1.219 | 105.290 | 1.526 |
201806 | 0.904 | 106.317 | 1.120 |
201809 | 0.967 | 106.507 | 1.196 |
201812 | 0.869 | 105.998 | 1.080 |
201903 | 0.625 | 107.251 | 0.768 |
201906 | 0.219 | 108.070 | 0.267 |
201909 | -0.215 | 108.329 | -0.262 |
201912 | -0.049 | 108.420 | -0.060 |
202003 | -0.555 | 108.902 | -0.672 |
202006 | 1.386 | 108.767 | 1.679 |
202009 | 1.216 | 109.815 | 1.459 |
202012 | 0.752 | 109.897 | 0.902 |
202103 | 2.483 | 111.754 | 2.928 |
202106 | 1.909 | 114.631 | 2.195 |
202109 | 5.146 | 115.734 | 5.859 |
202112 | 4.594 | 117.630 | 5.146 |
202203 | 4.277 | 121.301 | 4.646 |
202206 | 3.961 | 125.017 | 4.175 |
202209 | 3.776 | 125.227 | 3.973 |
202212 | 3.274 | 125.222 | 3.445 |
202303 | 2.990 | 127.348 | 3.094 |
202306 | 2.669 | 128.729 | 2.732 |
202309 | 2.412 | 129.860 | 2.448 |
202312 | 2.125 | 129.419 | 2.164 |
202403 | 1.868 | 131.776 | 1.868 |
Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.
Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.
Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.
If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.
Thank you for viewing the detailed overview of SILO Pharma's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Eric Weisblum | director, officer: President and CCO | 285 GRAND AVENUE, ENGLEWOOD NJ 07631 |
Daniel E. Ryweck | officer: Chief Financial Officer | 712 VISTA BLVD #305, WACONIA MN 55387 |
Jeff Pavell | director | 1 ROCKEFELLER PLAZA, SUITE 1039, NEW YORK NY 10020 |
Kevin Munoz | director | 560 SYLVAN AVE, SUITE 3160, ENGLEWOOD CLIFF NJ 07632 |
Wayne Linsley | director | 1 ROCKEFELLER PLAZA, SUITE 1039, NEW YORK NY 10020 |
Adam C Wasserman | officer: Chief Financial Officer | 1643 ROYAL GROVE WAY, WESTON FL 33327 |
Leonard M Schiller | director | |
Joel Alan Stone, | director | 1772 SABAL PALM DR., BOCA RATON FL 33432 |
Parker Walter Van Eps | director | C/O PROSPECT ENERGY CORPORATION, 10 E. 40TH STREET, 44TH FLOOR, NEW YORK NY 10016 |
Richard Brand | director, officer: Chairman and CEO | 10 E. 40TH STREET, 44TH FLOOR, NEW YORK NY 10016 |
Whalehaven Capital Fund Ltd | 10 percent owner | P O BOX HM 1027, HAMILTON D0 HMDX |
Vadim Mats | officer: VP of Business Development | 285 GRAND AVENUE, ENGLEWOOD NJ 07631 |
Donald Ptalis | director, officer: CFO | 72 POND ROAD, WOODBURY NY 11797 |
Melvin Schlossberg | director, 10 percent owner, officer: PRESIDENT, CEO & SECRETARY | 72 POND ROAD, WOODBURY NY 11797 |
From GuruFocus
By Stock market mentor Stock market mentor • 02-02-2023
By Marketwired • 10-16-2023
By sperokesalga sperokesalga • 06-13-2023
By sperokesalga sperokesalga • 03-27-2023
By Marketwired • 09-12-2023
By PRNewswire PRNewswire • 12-30-2022
By Value_Insider Value_Insider • 10-20-2022
By sperokesalga sperokesalga • 06-21-2023
By Stock market mentor Stock market mentor • 01-31-2023
By Stock market mentor Stock market mentor • 01-10-2023